We did not find a statistically significant correlation either between expressions of CD117/KIT in relation to HER2 and ERβ immunohistochemical positivity or between ERβ immunohistochemical expression in bladder carcinoma cases and HER2 expression where P > 0.05. Here, ERBB2 is linked to urinary bladder carcinoma.